Systemic AA amyloidosis: epidemiology, diagnosis, and management. - Wikidata - wikimedia - TriplyDB

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

http://www.wikidata.org/entity/Q34446219

about

Peptide-Induced Amyloid-Like Conformational Transitions in Proteins Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre.Gastrointestinal Amyloidosis: Review of the Literature.Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.Urethral Amyloidosis in a Patient with IgA Nephropathy After Renal Transplant.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.AA Amylodisis Associated with Jugular Paraganglioma as a Rare Cause of Chronic Diarrhea.A case of localized amyloidosis of the eyelid misdiagnosed as recurrent chalazion Periorbital Ecchymosis (Raccoon Eye) and Orbital Hematoma following Endoscopic Retrograde Cholangiopancreatography Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis.Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiology.Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.Distinct Secretory Activity and Clinical Impact of Subcutaneous Abdominal Adipose Tissue in Women with Rheumatoid Arthritis and Osteoarthritis.Response of Bortezomib Chemotherapy in Hepatic Amyloidosis.MRI of pathology-proven peripheral nerve amyloidosis.Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis.Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.Multiple papular lesions in a patient with HIV and/or AIDS and coinfected with hepatitis B virus: Amyloidosis.Inhibitory effect of propolis on the development of AA amyloidosis.Primary Sjogren syndrome diagnosed simultaneously with localized amyloidosis of the lacrimal gland: A case report.Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A

P2860

Q26782224-EF8CE3BA-31EB-45A5-8155-2C8408B297A7 Q35886290-17BD1351-014E-4E4E-8A19-5CEE198C5A53 Q38689671-9A291A30-82D2-48A8-900F-C0622F204296 Q39371045-51DEB241-5973-4362-BD78-7608C2F82A1E Q40073378-A3AAE808-47B2-4A8B-B4FC-1D34AA8BA3E1 Q40661190-4AA7F279-EFAD-4BEA-8BBF-15023557229D Q40986637-C264682A-5C11-408E-A07E-EE479F59F66E Q41106725-560F529F-741E-43E6-AF54-B4D055E548E8 Q41437808-9875EC35-4559-4FF3-90CE-6F18345A3E81 Q41505897-E0F45AAF-7D6D-4402-BC2C-07D8D96B7DA1 Q42158508-CB47114C-9666-4191-886A-E1F16BB8021D Q45903141-BD1BE265-B028-40B1-9160-0C1E853BBBCC Q47306597-349CFC3C-26B2-4B7B-A640-FD2B82506901 Q49917457-866B55AC-C297-4A2C-B6E7-184FEC1B074F Q51354466-BFC7F255-7B43-4493-BCB9-B2D0B8BD15B4 Q52649453-9A859120-C52F-4375-87F3-E9BD474B58E5 Q53011553-1969C0D3-2B3B-4806-BCD3-05F96DE26C10 Q53174546-5F1CCDA7-789B-4678-8548-F7979B3725FF Q53279630-6867C027-8512-4897-B652-3C948723AB5C Q53695989-2BFDB411-0CEE-43BE-9299-DD18B6126992 Q53699100-4BF80A35-58DD-4689-83B3-56F50C104AF7 Q54082926-A24301D7-DBEF-4C79-BDE5-06353CD263B1 Q55285618-FDC455C6-3CFB-4831-BE5E-A7BD6EBF4DD6 Q58134438-82CA67DF-5321-43E4-BA13-060CEBB7D0AC

P2860

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

http://www.wikidata.org/entity/Q34446219

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@ast

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@en

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@nl

type

label

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@ast

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@en

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@nl

prefLabel

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@ast

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@en

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@nl

P1433

Q34446219-6AA352C2-45D2-48E7-918E-92649DA46E45

P1476

Q34446219-785820D6-806E-4730-82DC-71E4E8888394

P2093

Q34446219-0E4C3532-6160-4FFE-B7C4-E8FD6A816F21

Q34446219-318AB851-BB54-47B7-9BED-D74B196AA85F

Q34446219-9B2D3311-DF45-41C9-BFA8-85EEA83D4F13

Q34446219-A820BEFB-F640-4C4A-A027-EF7451699104

Q34446219-C807006D-00F1-4C05-81A0-3B9D9169C0EC

Q34446219-D6A4CFC3-15F0-4647-9E97-CE3C93B3E8C6

P2860

Q34446219-00140177-B4C3-4FF3-8F09-28101CCD33B5

Q34446219-04D9282E-BEC8-4112-806C-2B29CE7D7E65

Q34446219-07CC4B33-29CF-4CA5-A600-3D7443086ADC

Q34446219-0B6928F2-2025-49C4-9187-8F9096EE3BD7

Q34446219-1703D133-3AB2-4BDD-8748-17F248493C8A

Q34446219-1CE2E2C1-6CB3-4F6B-AFBD-7E6ABD4F066F

Q34446219-247D02A1-0DF7-436C-B89D-7818528CCEE3

Q34446219-28E12A69-9AF1-4CFD-A3DA-BF44ABA88706

Q34446219-2F40850E-1AD3-441A-98F5-6A5A7AA16BBB

Q34446219-3195878C-65EA-479F-B0C6-88905667B725

P304

Q34446219-AA787D08-070C-4BAD-873F-762816375EA0

P31

Q34446219-43A1DCA1-FA44-4032-9C6A-DE26946D72D8

P356

Q34446219-85EE3A96-92AC-4C37-ACA1-09F5571B4554

P407

Q34446219-9AF6173A-9F84-44CA-A307-09BD014FC2CB

P478

Q34446219-71D0212F-1B7D-43A8-9F64-6C514D670DB7

P577

Q34446219-25B96BC4-2CB1-40B0-B447-CD9516B24F3B

P698

Q34446219-75A49201-7F0B-4F99-861B-FFEF257AD072

P932

Q34446219-58E96938-4FCD-4B64-AACF-3585293ECCEA

P356

P1433

Clinical Epidemiology

P1476

Systemic AA amyloidosis: epidemiology, diagnosis, and management.

@en

P2093

Davinia Trujillo

http://www.w3.org/2001/XMLSchema#string

Diego Real de Asúa

http://www.w3.org/2001/XMLSchema#string

Jose María Galván

http://www.w3.org/2001/XMLSchema#string

Julen Cadiñanos

http://www.w3.org/2001/XMLSchema#string

María Teresa Filigheddu

http://www.w3.org/2001/XMLSchema#string

Ramón Costa

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of amyloidosis using low-molecular-weight heparins

Incidence and survival in non-hereditary amyloidosis in Sweden

Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states.

A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.

Clinical profile of patients having pulmonary tuberculosis and renal amyloidosis

Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.

Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update.

P304

369-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CLEP.S39981

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25378951

http://www.w3.org/2001/XMLSchema#string

P932

4218891

http://www.w3.org/2001/XMLSchema#string